{
  "docId": "019de076-a4b3-719a-94d2-ca29be1b4679",
  "docSlug": "0f14c676100503df3bb87c658cc9d332",
  "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides",
  "authorId": "fusion-pharmaceuticals",
  "authorName": "Fusion Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 26,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "unfair_advantage",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide highlights a partnership-based supply chain and a proprietary onsite generator technology to mitigate risks associated with traditional cyclotron production.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/12",
  "deckHref": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
  "deckJsonHref": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json",
  "deckAnchorHref": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.94,
        "x": 0.03,
        "y": 0.38
      },
      "kind": "callout",
      "text": "Onsite actinium production builds capacity and flexibility into our manufacturing schedule",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67b81829-3366-4108-aab6-ae4cfd6928df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.52,
        "x": 0.45,
        "y": 0.48
      },
      "kind": "diagram",
      "text": "Ra-225 -> Generator -> Ac-225 -> TAT Production -> Clinical Site",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3668b45-ad67-4e35-adee-9b5fac265cb2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.6,
        "y": 0.18
      },
      "kind": "image",
      "text": "BWXT Medical, US Department of Energy, Niowave",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54ea5d7e-b51f-498f-8aa5-abdf997b1075",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.33,
        "x": 0.03,
        "y": 0.75
      },
      "kind": "list",
      "text": "Ra-225 continually decays to Ac-225; Ra-225 can be produced from a naturally occurring element",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e88b3277-d271-4d58-9c59-e562e1aea8db",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.33,
        "x": 0.03,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Generator technology through collaboration with BWXT Medical enables actinium-225 production on site at Fusion's GMP manufacturing facility without the significant capital investment and operating costs and risks of cyclotron-based methods.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27ac254d-7b33-405e-9cc9-51ba9c48b551",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.03,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Fusion's multiple strategic actinium supply agreements provide preferential access and pricing to actinium and ability to scale to meet anticipated Phase 3 and potential commercial needs.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7ac176e-285c-403b-aaf3-a9fdc7e8daa8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Fusion's Actinium Supply Designed to Provide Execution Advantage",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc767dcb-9f17-41f5-8f93-2024faa830f5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "value-chain",
      "slug": null,
      "matchId": "cbe47792-9c72-456c-a463-84ce2c86cdad",
      "evidence": "The diagram illustrates the flow from raw material (Ra-225) through production to clinical site.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}